Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
NovoCure Limited - Ordinary Shares
(NQ:
NVCR
)
11.36
-0.03 (-0.26%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about NovoCure Limited - Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Novocure Plummets 34% After Its Cancer Treatment Fails In Ovarian Cancer
↗
August 28, 2023
The company tested a regimen of chemotherapy and its tumor-treating fields.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
August 28, 2023
Via
Benzinga
Could NovoCure Stock Help You Become a Millionaire?
↗
August 25, 2023
The stock has some significant upside, but it also comes with considerable risks and volatility.
Via
The Motley Fool
2 Incredibly Cheap Growth Stocks to Buy in August
↗
August 09, 2023
These two innovative growth stocks appear deeply undervalued based on their long-term potential.
Via
The Motley Fool
Is NovoCure Stock a Buy Now?
↗
August 09, 2023
There's nobody else angling for its market share, but that might not be enough.
Via
The Motley Fool
Why Novocure Was a Healthy Stock Today
↗
August 08, 2023
The company stands to win big if its cancer-fighting technology does well in a late-stage clinical trial.
Via
The Motley Fool
What 9 Analyst Ratings Have To Say About NovoCure
↗
August 04, 2023
Via
Benzinga
NovoCure (NVCR) Q2 2023 Earnings Call Transcript
↗
July 27, 2023
NVCR earnings call for the period ending June 30, 2023.
Via
The Motley Fool
NovoCure Earnings Preview
↗
July 26, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
↗
August 08, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023
↗
August 04, 2023
Via
Benzinga
Here's Why Novocure Stock Dropped 42% in June
↗
July 06, 2023
The healthcare company presented the results of an important clinical trial that has mixed implications for its future cash flows.
Via
The Motley Fool
Stocks That Hit 52-Week Lows On Tuesday
↗
August 01, 2023
On Tuesday, 46 stocks hit new 52-week lows.
Via
Benzinga
Why Novocure Stock Tumbled by Nearly 16% Today
↗
July 27, 2023
The company posted a notably deeper net loss in its freshly reported quarter, while its revenue fell.
Via
The Motley Fool
Stocks That Hit 52-Week Lows On Thursday
↗
July 27, 2023
During Thursday, 56 stocks hit new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
↗
July 31, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
July 21, 2023
On Friday, 54 companies hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
July 28, 2023
Friday's session saw 59 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
July 20, 2023
During Thursday's session, 40 stocks hit new 52-week lows.
Via
Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
July 27, 2023
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
July 17, 2023
On Monday, 50 companies reached new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
July 24, 2023
On Monday morning, 70 companies achieved new lows for the year.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
July 06, 2023
Via
Benzinga
3 Small-Cap Drug Stocks to Watch as Their Clinical Trials End Soon
↗
June 12, 2023
These three small cap drug companies could become gold or lead depending on the outcomes of their clinical trials.
Via
InvestorPlace
This Beaten-Down Growth Stock Has 99% Upside, According to Wall Street
↗
June 12, 2023
A big turnaround could be in the cards for this medical device maker.
Via
The Motley Fool
Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review
↗
June 09, 2023
The Nasdaq held near 52-week highs while small caps ramped up.
Via
Investor's Business Daily
Stocks That Hit 52-Week Lows On Wednesday
↗
June 07, 2023
On Wednesday, 29 companies set new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
↗
June 07, 2023
Via
Benzinga
These 2 Nasdaq Stocks Are Plunging. Here's Why
↗
June 06, 2023
Tuesday brought optimism to the stock market overall, but not for these companies.
Via
The Motley Fool
Dow Falls Over 100 Points; Hoth Therapeutics Shares Spike Higher
↗
June 06, 2023
U.S. stocks traded mixed toward the end of trading, with Dow Jones dropping over 100 points on Tuesday. The Dow traded down 0.36% to 33,440.78 while the NASDAQ rose 0.09% to 13,241.04. The S&P 500,...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.